Multiply Labs

Multiply Labs

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.multiplylabs.com

Last Round

Early Funding

Mar 18, 2026

Est. Valuation

$1.71M

Total Funding Raised

$43.42M

Company Overview

Multiply Labs is a biotechnology company that creates advanced robotics technology for the production of personalized pharmaceutical capsules tailored to the specific metabolic needs of each patient at a reduced cost.

Sector

Healthcare & Life Sciences

Verticals

Industrial Robotics, Biotech Equipment, Precision Medicine, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

cell therapy manufacturingrobotic manufacturingautonomous manufacturingpharma roboticspersonalized medicinedrug manufacturing automationrobotics as a serviceRaaSCAR-T manufacturingmodular roboticslab automationbiopharma manufacturingimitation learningGMP manufacturingcloud-controlled manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Multiply Labs Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Multiply Labs Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 18, 2026
Series A ExtensionApr 10, 2023
Series AApr 14, 2021
SeedMay 1, 2017
AcceleratorAug 1, 2016

Key People

Founding team and executive leadership

Fred Parietti

Co-Founder And CEO

Founding Team

Multiply Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Study in Cytotherapy highlights statistical equivalence of automated cell expansion.

  • Sep 30, 2025

    Collaboration with Thermo Fisher Scientific has been expanded.

Multiply Labs Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Multiply Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Multiply Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range62
Year Founded2016
Last FundingMar 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.